Risk of falls in postmenopausal women treated with romosozumab: Preliminary indices from a meta-analysis of randomized, controlled trials.

Osteoporos Sarcopenia · 2020 · PMC7093685 · PMID 32226829

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a positive trendno p-value reported

Conclusions Our analysis indicates, based on the currently available, very limited amount of data, a positive trend for romosozumab on the reduction of risk for falls in postmenopausal women.

also in 11,005 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.